<DOC>
	<DOCNO>NCT01264692</DOCNO>
	<brief_summary>The purpose study demonstrate antihypertensive efficacy daily oral administration ACT 280778 DBP compare placebo 28 day .</brief_summary>
	<brief_title>Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Males female age 18 75 year ( inclusive ) screening . Body mass index ( BMI ) 18 35 kg/m2 ( inclusive ) body weight least 50 kg screen prior enrollment . 12lead ECG without clinically relevant abnormality measure screen . Clinical chemistry , hematology , coagulation , virus serology , urinalysis test result deviate clinically relevant extent normal range screening . Signed informed consent local language prior studymandated procedure Mean SBP &gt; 180 mmHg . Severe , malignant , secondary hypertension . Episodes hypertensive crisis hypertensive emergency within 6 month prior enrollment . Previous history fainting , collapse , syncope , orthostatic hypotension , vasovagal reaction consider clinical significance . E6 Severe coronary artery disease indicate myocardial infarction , percutaneous coronary intervention , coronary artery bypass graft within last 12 month prior enrollment . Angina pectoris within 6 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>